Uncoupling protein 2 knockout exacerbates depression-like behaviors in mice via enhancing inflammatory response

Neuroscience

Volumn 192, Issue , 2011, Pages 507-514

  Sun, X L ^a   Liu, Y ^a   Dai, T ^a   Ding, J H ^a   Hu, G ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chronic mild stress; Nuclear factor B; Tumor necrosis factor alpha; Uncoupling protein 2

Indexed keywords

CORTICOSTERONE; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DISEASE EXACERBATION; HYPOTHALAMUS; INFLAMMATION; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN; TISSUE LEVEL; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSION; DISEASE MODELS, ANIMAL; INFLAMMATION; ION CHANNELS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052263109     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.047     Document Type: Article

References (56)

1. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:355-364.
2. Andrews Z.B., Diano S., Horvath T.L. Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Nat Rev Neurosci 2005, 6:829-840.
3. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., Couplan E., Alves-Guerra M.C., Goubern M., Surwit R., Bouillaud F., Richard D., Collins S., Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000, 26:435-439.
4. Arvin B., Neville L.F., Barone F.C., Feuerstein G.Z. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996, 20:445-452.
5. Bai Y., Onuma H., Bai X., Medvedev A.V., Misukonis M., Weinberg J.B., Cao W., Robidoux J., Floering L.M., Daniel K.W., Collins S. Persistent nuclear factor-kappa B activation in UCP2-/- mice leads to enhanced nitric oxide and inflammatory cytokine production. J Biol Chem 2005, 280:19062-19069.
6. Beratis S., Katrivanou A., Georgiou S., Monastirli A., Pasmatzi E., Gourzis P., Tsambaos D. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment. J Psychosom Res 2005, 58:15-18.
7. Brouwer J.P., Appelhof B.C., van Rossum E.F., Koper J.W., Fliers E., Huyser J., Schene A.H., Tijssen J.G., Van Dyck R., Lamberts S.W., Wiersinga W.M., Hoogendijk W.J. Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression. Psychoneuroendocrinology 2006, 31:1154-1163.
8. Capuron L., Hauser P., Hinze-Selch D., Miller A.H., Neveu P.J. Treatment of cytokine-induced depression. Brain Behav Immun 2002, 16:575-580.
9. Clouse R.E., Lustman P.J., Freedland K.E., Griffith L.S., McGill J.B., Carney R.M. Depression and coronary heart disease in women with diabetes. Psychosom Med 2003, 65:376-383.
10. Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin 2006, 24:441-460.
11. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosciv9 2008, 46-56.
12. Delmastro K., Hellem T., Kim N., Kondo D., Sung Y.H., Renshaw P.F. Incidence of major depressive episode correlates with elevation of substate region of residence. J Affect Disord 2011, 129:376-379.
13. Diehl A.M., Hoek J.B. Mitochondrial uncoupling: role of uncoupling protein anion carriers and relationship to thermogenesis and weight control "the benefits of losing control". J Bioenerg Biomembr 1999, 31:493-506.
14. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
15. Emre Y., Hurtaud C., Karaca M., Nubel T., Zavala F., Ricquier D. Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes. Proc Natl Acad Sci U S A 2007, 104:19085-19090.
16. Emre Y., Hurtaud C., Nubel T., Criscuolo F., Ricquier D., Cassard-Doulcier A.M. Mitochondria contribute to LPS-induced MAPK activation via uncoupling protein UCP2 in macrophages. Biochem J 2007, 402:271-278.
17. Gabbay V., Klein R.G., Alonso C.M., Babb J.S., Nishawala M., De Jesus G., Hirsch G.S., Hottinger-Blanc P.M., Gonzalez C.J. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord 2009, 115:177-182.
18. Gabbay V., Klein R.G., Guttman L.E., Babb J.S., Alonso C.M., Nishawala M., Katz Y., Gaite M.R., Gonzalez C.J. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. J Child Adolesc Psychopharmacol 2009, 19:423-430.
19. Ghaemi S.N. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord 2008, 10:957-968.
20. Gong Y., Chai Y., Ding J.H., Sun X.L., Hu G. Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain. Neurosci Lett 2011, 488:76-80.
21. Graeff F.G., Guimaraes F.S., De Andrade T.G., Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996, 54:129-141.
22. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res 2007, 181:42-51.
23. Haines B.A., Mehta S.L., Pratt S.M., Warden C.H., Li P.A. Deletion of mitochondrial uncoupling protein-2 increases ischemic brain damage after transient focal ischemia by altering gene expression patterns and enhancing inflammatory cytokines. J Cereb Blood Flow Metab 2010, 30:1825-1833.
24. Hosoi T., Okuma Y., Nomura Y. The mechanisms of immune-to-brain communication in inflammation as a drug target. Curr Drug Targets Inflamm Allergy 2002, 1:257-262.
25. Kang M., Pyun K.H., Jang C.G., Kim H., Bae H., Shim I. Nelumbinis Semen reverses a decrease in hippocampal 5-HT release induced by chronic mild stress in rats. J Pharm Pharmacol 2005, 57:651-656.
26. Kim Y.K., Na K.S., Shin K.H., Jung H.Y., Choi S.H., Kim J.B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1044-1053.
27. Kubera M., Maes M., Holan V., Basta-Kaim A., Roman A., Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J Affect Disord 2001, 63:171-178.
28. Lanni C., Govoni S., Lucchelli A., Boselli C. Depression and antidepressants: molecular and cellular aspects. Cell Mol Life Sci 2009, 66:2985-3008.
29. Leonard B.E. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 2005, 20(Suppl 3):S302-S306.
30. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008, 29:287-291.
31. Mattiasson G., Sullivan P.G. The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal 2006, 8:1-38.
32. Mineur Y.S., Belzung C., Crusio W.E. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav Brain Res 2006, 175:43-50.
33. Nishio K., Qiao S., Yamashita H. Characterization of the differential expression of uncoupling protein 2 and ROS production in differentiated mouse macrophage-cells (Mm1) and the progenitor cells (M1). J Mol Histol 2005, 36:35-44.
34. O'Toole S.M., Sekula L.K., Rubin R.T. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. Biol Psychiatry 1997, 42:85-89.
35. Pace T.W., Miller A.H. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci 2009, 1179:86-105.
36. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., Heim C.M. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 2006, 163:1630-1633.
37. Pedreanez A., Arcaya J.L., Carrizo E., Mosquera J. Forced swimming test increases superoxide anion positive cells and angiotensin II positive cells in the cerebrum and cerebellum of the rat. Brain Res Bull 2006, 71:18-22.
38. Pelissolo A. Depression and pain: prevalence and clinical implication. Presse Med 2009, 38:385-391.
39. Raison C.L., Demetrashvili M., Capuron L., Miller A.H. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 2005, 19:105-123.
40. Richard D., Clavel S., Huang Q., Sanchis D., Ricquier D. Uncoupling protein 2 in the brain: distribution and function. Biochem Soc Trans 2001, 29:812-817.
41. Rousset S., Emre Y., Join-Lambert O., Hurtaud C., Ricquier D., Cassard-Doulcier A.M. The uncoupling protein 2 modulates the cytokine balance in innate immunity. Cytokine 2006, 35:135-142.
42. Rubin R.T., O'Toole S.M., Rhodes M.E., Sekula L.K., Czambel R.K. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects. Psychiatry Res 1999, 89:1-20.
43. Schaefer M., Schwaiger M., Garkisch A.S., Pich M., Hinzpeter A., Uebelhack R., Heinz A., van Boemmel F., Berg T. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol 2005, 42:793-798.
44. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:201-217.
45. Schweizer M.C., Henniger M.S., Sillaber I. Chronic mild stress (CMS) in mice: of anhedonia, "anomalous anxiolysis" and activity. PLoS One 2009, 4:e4326.
46. Stein D.J., Daniels W.M., Savitz J., Harvey B.H. Brain-derived neurotrophic factor: the neurotrophin hypothesis of psychopathology. CNS Spectr 2008, 13:945-949.
47. Stella F., Banzato C.E., Gasparetto Se E.V., Scudeler J.L., Pacheco J.L., Kajita R.T. Risk factors for vascular dementia in elderly psychiatric outpatients with preserved cognitive functions. J Neurol Sci 2007, 257:247-249.
48. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., Hen R., Belzung C. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008, 64:293-301.
49. Surtees P.G., Wainwright N.W., Luben R.N., Wareham N.J., Bingham S.A., Khaw K.T. Psychological distress, major depressive disorder, and risk of stroke. Neurology 2008, 70:788-794.
50. Tagliari B., dos Santos T.M., Cunha A.A., Lima D.D., Delwing D., Sitta A., Vargas C.R., Dalmaz C., Wyse A.T. Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats. J Neural Transm 2010, 117:1067-1076.
51. Thase M.E. Evaluating atypical antipsychotics in the treatment of refractory depression. J Clin Psychiatry 2009, 70:e14.
52. Tsuboyama-Kasaoka N., Sano K., Shozawa C., Osaka T., Ezaki O. Studies of UCP2 transgenic and knockout mice reveal that liver UCP2 is not essential for the antiobesity effects of fish oil. Am J Physiol Endocrinol Metab 2008, 294:E600-E606.
53. Vancassel S., Leman S., Hanonick L., Denis S., Roger J., Nollet M., Bodard S., Kousignian I., Belzung C., Chalon S. n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. J Lipid Res 2008, 49:340-348.
54. Vogler S., Pahnke J., Rousset S., Ricquier D., Moch H., Miroux B., Ibrahim S.M. Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. Am J Pathol 2006, 168:1570-1575.
55. Yonezawa T., Kurata R., Hosomichi K., Kono A., Kimura M., Inoko H. Nutritional and hormonal regulation of uncoupling protein 2. IUBMB Life 2009, 61:1123-1131.
56. Zhang C.Y., Baffy G., Perret P., Krauss S., Peroni O., Grujic D., Hagen T., Vidal-Puig A.J., Boss O., Kim Y.B., Zheng X.X., Wheeler M.B., Shulman G.I., Chan C.B., Lowell B.B. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001, 105:745-755.